Transmanubrial osteomuscular sparing approach for resection of cervico-thoracic lesions
- PMID: 29221280
- PMCID: PMC5708451
- DOI: 10.21037/jtd.2017.08.99
Transmanubrial osteomuscular sparing approach for resection of cervico-thoracic lesions
Abstract
Background: To review our experience of transmanubrial osteomuscular sparing approach (TMA) for resection of various lesions involving the thoracic inlet and to prove the feasibility and safety of the approach.
Methods: Retrospective review of 58 consecutive cases, from April 2007 to January 2016, with surgical resection of cervico-thoracic lesions via TMA.
Results: There were 22 neurogenic tumors, 21 bronchogenic tumors, and 15 other cases in the study. There was no intraoperative or postoperative mortality. Mean postoperative stay was 10.5 days (3-33 days). Mean operation time was 179.0 mins (57-328 mins) and the mean volume of blood loss for bronchogenic tumors was 900 mL, which was similar to non-bronchogenic tumors (474 mL, P=0.103). Moreover, patients with malignant tumors had more intraoperative blood loss than patients with benign diseases did (847 versus 194 mL, P=0.001). R0 resection was achieved in 28 of 33 (84.8%) malignant cases. Tumor size was related to incomplete resection (8.19 vs. 5.72 cm, P=0.023) in malignancy. Five (8.6%) cases were complicated with chylothorax and all occurred in patients with left incision. All of 21 cases (100%) with brachial plexus compression symptom were relieved after surgery and 3 of 4 (75%) cases with Horner's syndrome were ameliorated postoperatively.
Conclusions: TMA can be carried out safely in treating various cervico-thoracic lesions with good resection rate. Left side procedure should be cautious of thoracic duct injury.
Keywords: Transmanubrial osteomuscular sparing approach (TMA); complication; surgical technique.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Figures
Similar articles
-
Dual approach for large mediastinal tumors in the thoracic outlet: transmanubrial osteomuscular sparing approach and video-assisted thoracoscopic surgery.J Cardiothorac Surg. 2019 Feb 26;14(1):42. doi: 10.1186/s13019-019-0863-5. J Cardiothorac Surg. 2019. PMID: 30808387 Free PMC article.
-
Transmanubrial osteomuscular sparing approach: different indications.Interact Cardiovasc Thorac Surg. 2010 Oct;11(4):482-4. doi: 10.1510/icvts.2010.243238. Epub 2010 Jul 19. Interact Cardiovasc Thorac Surg. 2010. PMID: 20643819
-
Cervico-thoracic tumors resection through transmanubrial osteomuscular sparing approach.Eur J Cardiothorac Surg. 1999 Nov;16(5):564-7. doi: 10.1016/s1010-7940(99)00311-5. Eur J Cardiothorac Surg. 1999. PMID: 10609909
-
The transmanubrial osteomuscular-sparing approach: a valuable adjunct to the head and neck surgical armamentarium.Curr Opin Otolaryngol Head Neck Surg. 2020 Apr;28(2):61-67. doi: 10.1097/MOO.0000000000000605. Curr Opin Otolaryngol Head Neck Surg. 2020. PMID: 32011400 Review.
-
Transmanubrial osteomuscular sparing approach for lung cancer invading the anterior part of the thoracic inlet.Gen Thorac Cardiovasc Surg. 2010 Mar;58(3):149-54. doi: 10.1007/s11748-009-0484-3. Epub 2010 Mar 28. Gen Thorac Cardiovasc Surg. 2010. PMID: 20349307 Review.
Cited by
-
CircITGA7 Suppresses Gastric Cancer Progression Through miR-1471/MTDH Axis.Front Cell Dev Biol. 2021 Aug 24;9:688970. doi: 10.3389/fcell.2021.688970. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34504842 Free PMC article.
-
Integrative Analysis of Differently Expressed Genes Reveals a 17-Gene Prognosis Signature for Endometrial Carcinoma.Biomed Res Int. 2021 Jul 14;2021:4804694. doi: 10.1155/2021/4804694. eCollection 2021. Biomed Res Int. 2021. PMID: 34337010 Free PMC article.
-
miR-101-3p Serves as a Tumor Suppressor for Renal Cell Carcinoma and Inhibits Its Invasion and Metastasis by Targeting EZH2.Biomed Res Int. 2021 Jul 7;2021:9950749. doi: 10.1155/2021/9950749. eCollection 2021. Biomed Res Int. 2021. PMID: 34307682 Free PMC article.
-
Long Non-coding RNA FIRRE Acts as a miR-520a-3p Sponge to Promote Gallbladder Cancer Progression via Mediating YOD1 Expression.Front Genet. 2021 Jun 8;12:674653. doi: 10.3389/fgene.2021.674653. eCollection 2021. Front Genet. 2021. PMID: 34168678 Free PMC article.
-
Reverse "L" surgical approach for the management of giant tumors of the cervicothoracic junction.J Thorac Dis. 2020 Aug;12(8):3995-4001. doi: 10.21037/jtd-20-288B. J Thorac Dis. 2020. PMID: 32944311 Free PMC article.
References
-
- Dartevelle PG, Chapelier AR, Macchiarini P, et al. Anterior transcervical-thoracic approach for radical resection of lung tumors invading the thoracic inlet. J Thorac Cardiovasc Surg 1993;105:1025-34. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous